Concepts (278)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 46 | 2024 | 955 | 7.510 |
Why?
|
| School Health Services | 9 | 2023 | 85 | 4.350 |
Why?
|
| Risk-Taking | 21 | 2016 | 159 | 2.870 |
Why?
|
| Sexually Transmitted Diseases | 11 | 2022 | 95 | 2.240 |
Why?
|
| Adolescent Behavior | 10 | 2016 | 194 | 1.870 |
Why?
|
| Sex Work | 9 | 2016 | 19 | 1.630 |
Why?
|
| Sexual Behavior | 15 | 2016 | 191 | 1.620 |
Why?
|
| Bahamas | 16 | 2023 | 22 | 1.550 |
Why?
|
| Parent-Child Relations | 7 | 2015 | 67 | 1.500 |
Why?
|
| Condoms | 16 | 2016 | 47 | 1.400 |
Why?
|
| Health Knowledge, Attitudes, Practice | 17 | 2024 | 767 | 1.310 |
Why?
|
| Adolescent | 44 | 2024 | 6293 | 1.310 |
Why?
|
| China | 25 | 2018 | 175 | 1.280 |
Why?
|
| Homosexuality, Male | 7 | 2024 | 29 | 1.210 |
Why?
|
| Students | 10 | 2022 | 225 | 1.170 |
Why?
|
| Transients and Migrants | 6 | 2014 | 26 | 1.140 |
Why?
|
| Anti-HIV Agents | 4 | 2024 | 139 | 1.110 |
Why?
|
| Pre-Exposure Prophylaxis | 3 | 2024 | 15 | 1.070 |
Why?
|
| Evidence-Based Practice | 3 | 2016 | 84 | 0.980 |
Why?
|
| Transgender Persons | 2 | 2024 | 69 | 0.950 |
Why?
|
| Rural Population | 11 | 2024 | 223 | 0.930 |
Why?
|
| Risk Reduction Behavior | 8 | 2017 | 121 | 0.920 |
Why?
|
| School Teachers | 3 | 2023 | 8 | 0.880 |
Why?
|
| Parenting | 3 | 2015 | 75 | 0.850 |
Why?
|
| Peer Group | 2 | 2015 | 113 | 0.800 |
Why?
|
| Humans | 81 | 2024 | 64958 | 0.790 |
Why?
|
| Sex Workers | 3 | 2018 | 17 | 0.760 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2023 | 49 | 0.740 |
Why?
|
| Drug Users | 2 | 2024 | 29 | 0.740 |
Why?
|
| Sex Education | 6 | 2022 | 27 | 0.740 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2022 | 129 | 0.710 |
Why?
|
| Social Stigma | 4 | 2024 | 76 | 0.710 |
Why?
|
| Adult | 42 | 2024 | 17314 | 0.670 |
Why?
|
| Program Evaluation | 6 | 2023 | 493 | 0.670 |
Why?
|
| Unsafe Sex | 6 | 2013 | 27 | 0.660 |
Why?
|
| Curriculum | 4 | 2022 | 608 | 0.660 |
Why?
|
| Stereotyping | 3 | 2024 | 19 | 0.660 |
Why?
|
| Child | 17 | 2023 | 4606 | 0.660 |
Why?
|
| Male | 52 | 2024 | 30957 | 0.650 |
Why?
|
| Female | 55 | 2024 | 33929 | 0.650 |
Why?
|
| Program Development | 3 | 2016 | 208 | 0.580 |
Why?
|
| Research Design | 1 | 2022 | 585 | 0.580 |
Why?
|
| Surveys and Questionnaires | 17 | 2024 | 2759 | 0.560 |
Why?
|
| Safe Sex | 6 | 2022 | 25 | 0.560 |
Why?
|
| Asthma | 1 | 2023 | 483 | 0.550 |
Why?
|
| Population Dynamics | 4 | 2014 | 21 | 0.550 |
Why?
|
| Schools | 6 | 2022 | 170 | 0.540 |
Why?
|
| Social Networking | 1 | 2018 | 23 | 0.540 |
Why?
|
| Self Efficacy | 10 | 2019 | 204 | 0.540 |
Why?
|
| Health Education | 3 | 2014 | 188 | 0.530 |
Why?
|
| Cross-Sectional Studies | 17 | 2024 | 2702 | 0.520 |
Why?
|
| Medication Adherence | 4 | 2024 | 199 | 0.520 |
Why?
|
| Single Person | 2 | 2007 | 4 | 0.510 |
Why?
|
| Mental Health | 6 | 2022 | 361 | 0.510 |
Why?
|
| Communication | 4 | 2016 | 595 | 0.510 |
Why?
|
| Prejudice | 4 | 2012 | 61 | 0.490 |
Why?
|
| Parents | 6 | 2016 | 413 | 0.480 |
Why?
|
| Alcohol Drinking | 5 | 2024 | 322 | 0.440 |
Why?
|
| Young Adult | 16 | 2024 | 4795 | 0.430 |
Why?
|
| Teaching | 1 | 2016 | 164 | 0.430 |
Why?
|
| Quality of Life | 3 | 2022 | 1255 | 0.390 |
Why?
|
| Risk Factors | 12 | 2024 | 5410 | 0.390 |
Why?
|
| Sexual Partners | 8 | 2016 | 76 | 0.380 |
Why?
|
| Substance Abuse, Intravenous | 2 | 2024 | 83 | 0.370 |
Why?
|
| Sexual and Gender Minorities | 2 | 2024 | 76 | 0.370 |
Why?
|
| Child, Orphaned | 1 | 2012 | 5 | 0.370 |
Why?
|
| Residence Characteristics | 1 | 2014 | 230 | 0.360 |
Why?
|
| Syphilis | 1 | 2012 | 25 | 0.360 |
Why?
|
| Emigrants and Immigrants | 1 | 2012 | 47 | 0.350 |
Why?
|
| Depression | 2 | 2024 | 899 | 0.350 |
Why?
|
| Hepatitis C | 2 | 2024 | 145 | 0.350 |
Why?
|
| Urban Population | 6 | 2014 | 200 | 0.340 |
Why?
|
| Thailand | 6 | 2024 | 91 | 0.340 |
Why?
|
| Qualitative Research | 4 | 2024 | 745 | 0.320 |
Why?
|
| Cancer Survivors | 2 | 2023 | 128 | 0.320 |
Why?
|
| Physician-Patient Relations | 2 | 2024 | 427 | 0.320 |
Why?
|
| Coercion | 2 | 2007 | 60 | 0.310 |
Why?
|
| Faculty | 3 | 2022 | 58 | 0.310 |
Why?
|
| Zambia | 6 | 2024 | 19 | 0.290 |
Why?
|
| Refusal to Participate | 1 | 2008 | 1 | 0.290 |
Why?
|
| Coitus | 2 | 2012 | 15 | 0.290 |
Why?
|
| Health Status | 2 | 2007 | 447 | 0.270 |
Why?
|
| Battered Women | 1 | 2007 | 11 | 0.270 |
Why?
|
| Longitudinal Studies | 4 | 2016 | 1280 | 0.260 |
Why?
|
| Social Support | 4 | 2019 | 391 | 0.260 |
Why?
|
| Smoking Cessation | 2 | 2022 | 551 | 0.260 |
Why?
|
| Women's Health | 2 | 2007 | 374 | 0.250 |
Why?
|
| Prevalence | 6 | 2024 | 1439 | 0.250 |
Why?
|
| Disease Transmission, Infectious | 1 | 2007 | 20 | 0.250 |
Why?
|
| Deception | 1 | 2006 | 7 | 0.250 |
Why?
|
| Interviews as Topic | 5 | 2024 | 529 | 0.240 |
Why?
|
| Self Report | 2 | 2023 | 391 | 0.240 |
Why?
|
| Attitude to Health | 2 | 2008 | 296 | 0.240 |
Why?
|
| Socioeconomic Factors | 5 | 2021 | 801 | 0.240 |
Why?
|
| Vaginal Douching | 1 | 2005 | 3 | 0.240 |
Why?
|
| Caribbean Region | 2 | 2023 | 21 | 0.230 |
Why?
|
| Stress, Psychological | 1 | 2010 | 476 | 0.230 |
Why?
|
| Sex Characteristics | 1 | 2007 | 211 | 0.220 |
Why?
|
| Mental Disorders | 2 | 2022 | 815 | 0.220 |
Why?
|
| Health Behavior | 5 | 2022 | 483 | 0.210 |
Why?
|
| Psychometrics | 2 | 2018 | 391 | 0.200 |
Why?
|
| Motivational Interviewing | 2 | 2014 | 49 | 0.200 |
Why?
|
| Multivariate Analysis | 5 | 2014 | 929 | 0.190 |
Why?
|
| Suicidal Ideation | 1 | 2024 | 131 | 0.190 |
Why?
|
| Pediatrics | 2 | 2016 | 265 | 0.190 |
Why?
|
| Social Perception | 3 | 2019 | 42 | 0.190 |
Why?
|
| Zinc Oxide | 1 | 2022 | 6 | 0.190 |
Why?
|
| Pharmacies | 1 | 2023 | 36 | 0.190 |
Why?
|
| Sample Size | 1 | 2022 | 66 | 0.180 |
Why?
|
| Life Style | 1 | 2024 | 321 | 0.180 |
Why?
|
| Emergencies | 1 | 2022 | 122 | 0.180 |
Why?
|
| Computer Simulation | 2 | 2022 | 483 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2022 | 801 | 0.180 |
Why?
|
| Neoplasms | 2 | 2023 | 1365 | 0.180 |
Why?
|
| Perception | 3 | 2021 | 181 | 0.180 |
Why?
|
| Logistic Models | 5 | 2016 | 1270 | 0.180 |
Why?
|
| Cluster Analysis | 1 | 2022 | 261 | 0.170 |
Why?
|
| Disclosure | 2 | 2015 | 57 | 0.170 |
Why?
|
| Papillomavirus Vaccines | 1 | 2022 | 69 | 0.170 |
Why?
|
| Public Health | 1 | 2022 | 186 | 0.160 |
Why?
|
| Machine Learning | 1 | 2022 | 192 | 0.160 |
Why?
|
| Cognition Disorders | 1 | 2022 | 223 | 0.160 |
Why?
|
| Papillomavirus Infections | 1 | 2022 | 133 | 0.160 |
Why?
|
| Child, Preschool | 3 | 2022 | 2052 | 0.160 |
Why?
|
| Metal Nanoparticles | 1 | 2022 | 190 | 0.150 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2017 | 97 | 0.150 |
Why?
|
| Smoking | 4 | 2024 | 861 | 0.150 |
Why?
|
| Adaptation, Psychological | 2 | 2012 | 282 | 0.140 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 1141 | 0.140 |
Why?
|
| Substance-Related Disorders | 5 | 2013 | 750 | 0.140 |
Why?
|
| Hypertension | 1 | 2024 | 610 | 0.140 |
Why?
|
| Interpersonal Relations | 2 | 2012 | 160 | 0.140 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2019 | 94 | 0.140 |
Why?
|
| Anti-Retroviral Agents | 1 | 2019 | 76 | 0.140 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 25 | 0.140 |
Why?
|
| Internship and Residency | 2 | 2016 | 805 | 0.140 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 213 | 0.130 |
Why?
|
| Pandemics | 1 | 2022 | 672 | 0.130 |
Why?
|
| Follow-Up Studies | 5 | 2016 | 2482 | 0.130 |
Why?
|
| Noise, Occupational | 1 | 2017 | 13 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 350 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 382 | 0.130 |
Why?
|
| Population Surveillance | 1 | 2018 | 210 | 0.130 |
Why?
|
| Social Class | 3 | 2022 | 137 | 0.130 |
Why?
|
| Contraception Behavior | 3 | 2006 | 37 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2018 | 2094 | 0.120 |
Why?
|
| Apgar Score | 1 | 2016 | 10 | 0.120 |
Why?
|
| Models, Statistical | 1 | 2018 | 309 | 0.120 |
Why?
|
| Neonatology | 1 | 2016 | 5 | 0.120 |
Why?
|
| Suicide | 1 | 2018 | 146 | 0.120 |
Why?
|
| Nanoparticles | 1 | 2022 | 544 | 0.120 |
Why?
|
| Marijuana Smoking | 1 | 2016 | 19 | 0.120 |
Why?
|
| Health Promotion | 3 | 2011 | 512 | 0.120 |
Why?
|
| Choice Behavior | 3 | 2018 | 85 | 0.120 |
Why?
|
| Observer Variation | 1 | 2016 | 216 | 0.120 |
Why?
|
| Ketamine | 1 | 2016 | 39 | 0.120 |
Why?
|
| Audiovisual Aids | 1 | 2015 | 11 | 0.110 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 105 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 460 | 0.110 |
Why?
|
| Violence | 1 | 2016 | 171 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 206 | 0.110 |
Why?
|
| Health Personnel | 3 | 2024 | 384 | 0.100 |
Why?
|
| HIV Seropositivity | 1 | 2014 | 81 | 0.100 |
Why?
|
| Needle-Exchange Programs | 2 | 2024 | 16 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2024 | 496 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2012 | 602 | 0.100 |
Why?
|
| Juvenile Delinquency | 1 | 2013 | 56 | 0.090 |
Why?
|
| New England | 2 | 2024 | 270 | 0.090 |
Why?
|
| Models, Theoretical | 2 | 2012 | 273 | 0.090 |
Why?
|
| Quality Improvement | 1 | 2017 | 463 | 0.090 |
Why?
|
| Middle Aged | 6 | 2024 | 18210 | 0.090 |
Why?
|
| Hepacivirus | 2 | 2024 | 134 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 459 | 0.090 |
Why?
|
| Demography | 1 | 2012 | 178 | 0.090 |
Why?
|
| Social Environment | 1 | 2012 | 93 | 0.090 |
Why?
|
| Educational Status | 2 | 2011 | 278 | 0.090 |
Why?
|
| Motivation | 2 | 2019 | 294 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 414 | 0.080 |
Why?
|
| Tobacco, Smokeless | 1 | 2011 | 8 | 0.080 |
Why?
|
| Community-Based Participatory Research | 1 | 2011 | 62 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2022 | 3305 | 0.080 |
Why?
|
| Culture | 2 | 2008 | 82 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 795 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2011 | 525 | 0.070 |
Why?
|
| Referral and Consultation | 2 | 2023 | 439 | 0.070 |
Why?
|
| Cognition | 2 | 2022 | 503 | 0.070 |
Why?
|
| Patient Compliance | 2 | 2007 | 364 | 0.070 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2007 | 45 | 0.070 |
Why?
|
| Data Collection | 2 | 2006 | 382 | 0.060 |
Why?
|
| Comprehensive Health Care | 1 | 2007 | 19 | 0.060 |
Why?
|
| Counseling | 2 | 2007 | 375 | 0.060 |
Why?
|
| Social Values | 1 | 2006 | 16 | 0.060 |
Why?
|
| Social Change | 1 | 2006 | 13 | 0.060 |
Why?
|
| Academic Medical Centers | 2 | 2018 | 306 | 0.060 |
Why?
|
| Sex Factors | 1 | 2008 | 991 | 0.060 |
Why?
|
| Suburban Population | 1 | 2005 | 9 | 0.060 |
Why?
|
| Disease Outbreaks | 1 | 2006 | 110 | 0.060 |
Why?
|
| Occupational Diseases | 1 | 2007 | 265 | 0.060 |
Why?
|
| Exercise | 2 | 2023 | 961 | 0.060 |
Why?
|
| United States | 4 | 2024 | 8085 | 0.060 |
Why?
|
| Focus Groups | 1 | 2006 | 319 | 0.050 |
Why?
|
| Adolescent Health Services | 1 | 2004 | 19 | 0.050 |
Why?
|
| Reproductive Health Services | 1 | 2004 | 12 | 0.050 |
Why?
|
| Vietnam | 1 | 2024 | 185 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2014 | 5776 | 0.050 |
Why?
|
| Intention | 1 | 2023 | 73 | 0.050 |
Why?
|
| Syringes | 1 | 2023 | 12 | 0.050 |
Why?
|
| Needle Sharing | 1 | 2023 | 14 | 0.050 |
Why?
|
| HIV-1 | 1 | 2008 | 706 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2023 | 51 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 1161 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2018 | 1416 | 0.050 |
Why?
|
| Neurocognitive Disorders | 1 | 2022 | 7 | 0.050 |
Why?
|
| Larva | 1 | 2022 | 157 | 0.040 |
Why?
|
| Mississippi | 2 | 2012 | 15 | 0.040 |
Why?
|
| Geographic Information Systems | 1 | 2021 | 22 | 0.040 |
Why?
|
| Michigan | 2 | 2015 | 44 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 630 | 0.040 |
Why?
|
| Smokers | 1 | 2022 | 117 | 0.040 |
Why?
|
| Mass Screening | 1 | 2006 | 696 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2018 | 1013 | 0.040 |
Why?
|
| Developing Countries | 2 | 2014 | 87 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 410 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2012 | 6844 | 0.040 |
Why?
|
| Survivors | 1 | 2021 | 186 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 375 | 0.040 |
Why?
|
| Zebrafish | 1 | 2022 | 369 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 625 | 0.040 |
Why?
|
| Viral Load | 1 | 2019 | 230 | 0.030 |
Why?
|
| Time Factors | 2 | 2016 | 3758 | 0.030 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2017 | 5 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 1692 | 0.030 |
Why?
|
| Muscle Tonus | 1 | 2016 | 3 | 0.030 |
Why?
|
| Cyanosis | 1 | 2016 | 7 | 0.030 |
Why?
|
| Anesthetics, Dissociative | 1 | 2016 | 7 | 0.030 |
Why?
|
| Reflex | 1 | 2016 | 27 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 71 | 0.030 |
Why?
|
| Respiration | 1 | 2016 | 93 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2016 | 250 | 0.030 |
Why?
|
| Family | 1 | 2017 | 245 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2017 | 197 | 0.030 |
Why?
|
| Nurse Practitioners | 1 | 2016 | 120 | 0.030 |
Why?
|
| Heart Rate | 1 | 2016 | 331 | 0.030 |
Why?
|
| Occupational Health | 1 | 2016 | 193 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2016 | 200 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2016 | 739 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 856 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 1044 | 0.020 |
Why?
|
| Hospitals | 1 | 2015 | 386 | 0.020 |
Why?
|
| Infant | 1 | 2017 | 1683 | 0.020 |
Why?
|
| National Health Programs | 1 | 2012 | 20 | 0.020 |
Why?
|
| Food, Organic | 1 | 2011 | 4 | 0.020 |
Why?
|
| Smoking Prevention | 1 | 2012 | 163 | 0.020 |
Why?
|
| Inservice Training | 1 | 2012 | 85 | 0.020 |
Why?
|
| Cities | 1 | 2011 | 32 | 0.020 |
Why?
|
| Indians, North American | 1 | 2011 | 28 | 0.020 |
Why?
|
| Anthropometry | 1 | 2011 | 86 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2011 | 65 | 0.020 |
Why?
|
| Decision Making | 1 | 2015 | 417 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 2372 | 0.020 |
Why?
|
| Community Participation | 1 | 2011 | 48 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2011 | 93 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 735 | 0.020 |
Why?
|
| Energy Intake | 1 | 2011 | 173 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2015 | 727 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1580 | 0.020 |
Why?
|
| Motor Activity | 1 | 2011 | 343 | 0.020 |
Why?
|
| Psychological Theory | 1 | 2008 | 26 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 14926 | 0.020 |
Why?
|
| Universities | 1 | 2008 | 168 | 0.020 |
Why?
|
| Case Management | 1 | 2007 | 53 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2011 | 407 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2006 | 19 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2007 | 335 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 21292 | 0.010 |
Why?
|
| Alcoholism | 1 | 2007 | 327 | 0.010 |
Why?
|
| Comorbidity | 1 | 2007 | 1113 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 434 | 0.010 |
Why?
|